PGX · Class II · 21 CFR 866.2680

FDA Product Code PGX: Groups A, C And G Beta-hemolytic Streptococcus Nucleic Acid Amplification System

An In Vitro Diagnostic Test For The Detection Of Group A, C And G Beta Hemolytic Streptococcus In Throat Swab Specimens From Symptomatic Patients.

Leading manufacturers include Quidel Corporation, Cepheid and Alere Scarborough, Inc..

14
Total
13
Cleared
120d
Avg days
2014
Since
Growing category - 1 submissions in the last 2 years vs 0 in the prior period
Consistent review times: 133d avg (recent)

FDA 510(k) Cleared Groups A, C And G Beta-hemolytic Streptococcus Nucleic Acid Amplification System Devices (Product Code PGX)

14 devices
1–14 of 14

About Product Code PGX - Regulatory Context

510(k) Submission Activity

14 total 510(k) submissions under product code PGX since 2014, with 13 receiving FDA clearance (average review time: 120 days).

Submission volume has increased in recent years - 1 submissions in the last 24 months compared to 0 in the prior period - suggesting growing market activity in this device classification.

FDA 510(k) Review Time - PGX Product Code

FDA review times for PGX submissions have been consistent, averaging 133 days recently vs 119 days historically.

PGX devices are reviewed by the Microbiology panel. Browse all Microbiology devices →